Resistance to Bacillus thuringiensis toxin in Caenorhabditis elegans from loss of fucose

Resistance to Bacillus thuringiensis toxin in Caenorhabditis elegans from loss of fucose
复制标题

DOI:
10.1074/jbc.m606621200
复制
发表时间:
2007-02-02
影响因子:
4.8
通讯作者:
Aroian, Raffi V.
Aroian, Raffi V.
中科院分区:
生物学2区
文献类型:
--
作者:
Barrows, Brad D.;Haslam, Stuart M.;Aroian, Raffi V.

文献摘要

被引文献

相似文献

在苏云金芽孢杆菌抗Cry5B晶体毒素突变株的筛选中,分离到秀丽隐杆线虫Bre-1基因突变。Bre-1突变动物与其他四个克隆的Bre突变动物的不同之处在于它们的抵抗力水平明显较低。在25℃的温度下,BRE-1动物的孵化仔数也显著减少。在这里,我们克隆了BRE-1基因,并对BRE-1突变表型进行了表征。BRE-1编码一种与GDP-甘露糖4,6-脱水酶有显著同源性的蛋白质,该酶催化GDP-甘露糖生物合成GDP-岩藻糖的第一步。向线虫肠道细胞注射GDP-岩藻糖而不是岩藻糖可以挽救bre-1突变表型。因此,线虫缺乏功能性岩藻糖回收途径。此外,我们证明bre-1突变动物在岩藻糖化糖脂的产生方面存在缺陷,并且bre-1突变动物使Cry5B糖脂受体的数量水平降低。最后,我们发现,BRE-1突变动物,虽然活着,但根据质谱学证据,显示缺乏岩藻糖化的N-和O-多糖。因此,线虫可以在没有岩藻糖的情况下存活,并且可以通过失去单糖生物合成途径来对晶体毒素产生抗性。
A mutation in the Caenorhabditis elegans bre-1 gene was isolated in a screen for Bacillus thuringiensis toxin-resistant (bre) mutants to the Cry5B crystal toxin made by B. thuringiensis. bre-1 mutant animals are different from the four other cloned bre mutants in that their level of resistance is noticeably lower. bre-1 animals also display a significantly reduced brood size at 25 C. Here we cloned the bre-1 gene and characterized the bre-1 mutant phenotype. bre-1 encodes a protein with significant homology to a GDP-mannose 4,6-dehydratase, which catalyzes the first step in the biosynthesis of GDP-fucose from GDP-mannose. Injection of GDP-fucose but not fucose into C. elegans intestinal cells rescues bre-1 mutant phenotypes. Thus, C. elegans lacks a functional fucose salvage pathway. Furthermore, we demonstrate that bre-1 mutant animals are defective in production of fucosylated glycolipids and that bre-1 mutant animals make quantitatively reduced levels of glycolipid receptors for Cry5B. We finally show that bre-1 mutant animals, although viable, show a lack of fucosylated N-and O-glycans, based on mass spectrometric evidence. Thus, C. elegans can survive with little fucose and can develop resistance to crystal toxin by loss of a monosaccharide biosynthetic pathway.